Dysfunctional HDL in acute stroke.

[1]  Sherif Hafez,et al.  Response to Letter Regarding Article, "Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke". , 2016, Stroke.

[2]  Sherif Hafez,et al.  Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke , 2016, Stroke.

[3]  N. Schneiderman,et al.  HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis. , 2015, Atherosclerosis.

[4]  D. Kaimen-Maciel,et al.  Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes , 2015, Metabolic Brain Disease.

[5]  O. Meilhac.  High-density lipoproteins in stroke. , 2015, Handbook of experimental pharmacology.

[6]  R. Eckel,et al.  What are lipoproteins doing in the brain? , 2014, Trends in Endocrinology & Metabolism.

[7]  A. Kontush,et al.  Unraveling the complexities of the HDL lipidome1 , 2013, Journal of Lipid Research.

[8]  J. Michel,et al.  Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm. , 2013, Cardiovascular research.

[9]  P. Ridker,et al.  High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy , 2013, Circulation.

[10]  J. Martín-Ventura,et al.  HDL and endothelial protection , 2013, British journal of pharmacology.

[11]  S. Juo,et al.  A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis. , 2013, Atherosclerosis.

[12]  Quoc Bao Dang,et al.  High-Density Lipoproteins Limit Neutrophil-Induced Damage to the Blood–Brain Barrier in Vitro , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  A. Alavi,et al.  Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study. , 2012, American journal of cardiovascular disease.

[14]  P. Barter,et al.  Predictive value of different HDL particles for the protection against or risk of coronary heart disease. , 2012, Biochimica et biophysica acta.

[15]  A. Khera,et al.  The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease. , 2011, Journal of the American College of Cardiology.

[16]  A. Kontush,et al.  Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.

[17]  M. Gruber,et al.  Lipoprotein profile in patients who survive a stroke. , 2011, Neuro endocrinology letters.

[18]  J. Michel,et al.  Protective Effect of High-Density Lipoprotein-Based Therapy in a Model of Embolic Stroke , 2010, Stroke.

[19]  N. Bogavac-Stanojević,et al.  LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. , 2010, Atherosclerosis.

[20]  J. Heinecke,et al.  Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein. , 2010, Chemical research in toxicology.

[21]  Costantina Manes,et al.  Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy , 2010, Circulation.

[22]  R. Tanasescu,et al.  Plasma myeloperoxidase levels in patients with acute ischemic stroke. , 2010, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[23]  A. Burlingame,et al.  HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  M. Hennerici,et al.  Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial , 2009, Stroke.

[25]  M. Hennerici,et al.  Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. , 2009, Atherosclerosis.

[26]  J. Lau,et al.  Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes , 2009, Annals of Internal Medicine.

[27]  A. Kastrati,et al.  Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes , 2008, European journal of clinical investigation.

[28]  O. Bang,et al.  Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans. , 2007, Biochemical and biophysical research communications.

[29]  Subramaniam Pennathur,et al.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.

[30]  S. Taha,et al.  TNF-α and IL-8 in Acute Stroke and the Modulation of these Cytokines by Antiplatelet Agents , 2007 .

[31]  R. Keep,et al.  Effects of the Chemokine CCL2 on Blood–Brain Barrier Permeability during Ischemia–Reperfusion Injury , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  S. Reddy,et al.  The double jeopardy of HDL , 2005, Annals of medicine.

[34]  Per Leanderson,et al.  Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry , 2005, Proteomics.

[35]  Shirin Rahmani,et al.  Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment , 2003, Circulation.

[36]  P. Mecocci,et al.  Antioxidant Profile and Early Outcome in Stroke Patients , 2000, Stroke.

[37]  C. Guarnieri,et al.  Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism. , 1997, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.